Linoleic acid improves assembly of the CII subunit and CIII2/CIV complex of the mitochondrial oxidative phosphorylation system in heart failure.
Aged
Animals
Cardiolipins
/ metabolism
Electron Transport Complex II
/ chemistry
Electron Transport Complex III
/ metabolism
Electron Transport Complex IV
/ metabolism
Female
Heart Failure
/ metabolism
Humans
Linoleic Acid
/ metabolism
Male
Mice
Mitochondria, Heart
/ drug effects
Oxidative Phosphorylation
/ drug effects
Protein Subunits
/ metabolism
Cardiolipin
Myocardial infarction
Respirasome
Succinate dehydrogenase
Supercomplex
Journal
Cell communication and signaling : CCS
ISSN: 1478-811X
Titre abrégé: Cell Commun Signal
Pays: England
ID NLM: 101170464
Informations de publication
Date de publication:
16 10 2019
16 10 2019
Historique:
received:
26
05
2019
accepted:
24
09
2019
entrez:
18
10
2019
pubmed:
18
10
2019
medline:
14
7
2020
Statut:
epublish
Résumé
Linoleic acid is the major fatty acid moiety of cardiolipin, which is central to the assembly of components involved in mitochondrial oxidative phosphorylation (OXPHOS). Although linoleic acid is an essential nutrient, its excess intake is harmful to health. On the other hand, linoleic acid has been shown to prevent the reduction in cardiolipin content and to improve mitochondrial function in aged rats with spontaneous hypertensive heart failure (HF). In this study, we found that lower dietary intake of linoleic acid in HF patients statistically correlates with greater severity of HF, and we investigated the mechanisms therein involved. HF patients, who were classified as New York Heart Association (NYHA) functional class I (n = 45), II (n = 93), and III (n = 15), were analyzed regarding their dietary intakes of different fatty acids during the one month prior to the study. Then, using a mouse model of HF, we confirmed reduced cardiolipin levels in their cardiac myocytes, and then analyzed the mechanisms by which dietary supplementation of linoleic acid improves cardiac malfunction of mitochondria. The dietary intake of linoleic acid was significantly lower in NYHA III patients, as compared to NYHA II patients. In HF model mice, both CI-based and CII-based OXPHOS activities were affected together with reduced cardiolipin levels. Silencing of CRLS1, which encodes cardiolipin synthetase, in cultured cardiomyocytes phenocopied these events. Feeding HF mice with linoleic acid improved both CI-based and CII-based respiration as well as left ventricular function, together with an increase in cardiolipin levels. However, although assembly of the respirasome (i.e., CI/CIII Dietary supplement of linoleic acid is beneficial for improving cardiac malfunction in HF, but is unable to completely cure HF.
Sections du résumé
BACKGROUND
Linoleic acid is the major fatty acid moiety of cardiolipin, which is central to the assembly of components involved in mitochondrial oxidative phosphorylation (OXPHOS). Although linoleic acid is an essential nutrient, its excess intake is harmful to health. On the other hand, linoleic acid has been shown to prevent the reduction in cardiolipin content and to improve mitochondrial function in aged rats with spontaneous hypertensive heart failure (HF). In this study, we found that lower dietary intake of linoleic acid in HF patients statistically correlates with greater severity of HF, and we investigated the mechanisms therein involved.
METHODS
HF patients, who were classified as New York Heart Association (NYHA) functional class I (n = 45), II (n = 93), and III (n = 15), were analyzed regarding their dietary intakes of different fatty acids during the one month prior to the study. Then, using a mouse model of HF, we confirmed reduced cardiolipin levels in their cardiac myocytes, and then analyzed the mechanisms by which dietary supplementation of linoleic acid improves cardiac malfunction of mitochondria.
RESULTS
The dietary intake of linoleic acid was significantly lower in NYHA III patients, as compared to NYHA II patients. In HF model mice, both CI-based and CII-based OXPHOS activities were affected together with reduced cardiolipin levels. Silencing of CRLS1, which encodes cardiolipin synthetase, in cultured cardiomyocytes phenocopied these events. Feeding HF mice with linoleic acid improved both CI-based and CII-based respiration as well as left ventricular function, together with an increase in cardiolipin levels. However, although assembly of the respirasome (i.e., CI/CIII
CONCLUSIONS
Dietary supplement of linoleic acid is beneficial for improving cardiac malfunction in HF, but is unable to completely cure HF.
Identifiants
pubmed: 31619261
doi: 10.1186/s12964-019-0445-0
pii: 10.1186/s12964-019-0445-0
pmc: PMC6796462
doi:
Substances chimiques
Cardiolipins
0
Protein Subunits
0
Linoleic Acid
9KJL21T0QJ
Electron Transport Complex II
EC 1.3.5.1
Electron Transport Complex IV
EC 1.9.3.1
Electron Transport Complex III
EC 7.1.1.8
Types de publication
Clinical Trial
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
128Références
Expert Opin Investig Drugs. 2016 Jul;25(7):811-26
pubmed: 27104862
Chem Phys Lipids. 2014 Apr;179:42-8
pubmed: 24220496
Nat Rev Cardiol. 2011 Jan;8(1):30-41
pubmed: 21060326
Biochim Biophys Acta. 2012 Sep;1817(9):1588-96
pubmed: 22575443
Biosci Biotechnol Biochem. 2002 Jan;66(1):141-6
pubmed: 11866096
Am J Cardiol. 2003 May 8;91(9A):41F-50F
pubmed: 12729849
Free Radic Biol Med. 2010 Jul 1;49(1):96-108
pubmed: 20385227
J Biol Chem. 2013 Jan 4;288(1):401-11
pubmed: 23172229
Am J Physiol Heart Circ Physiol. 2015 May 15;308(10):H1237-47
pubmed: 25770243
J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):844-859
pubmed: 30168279
Am J Physiol Heart Circ Physiol. 2009 Sep;297(3):H1069-77
pubmed: 19617406
Lipids Health Dis. 2019 Feb 14;18(1):53
pubmed: 30764880
Nature. 2016 Oct 20;538(7625):406-410
pubmed: 27595392
Biochim Biophys Acta. 2012 May;1818(5):1309-17
pubmed: 22285120
J Physiol. 2015 Sep 1;593(17):3991-4010
pubmed: 26096709
Circ Res. 2000 Sep 1;87(5):392-8
pubmed: 10969037
J Nutr Health Aging. 2013 Jan;17(1):82-9
pubmed: 23299385
Nat Protoc. 2007;2(2):287-95
pubmed: 17406588
Acta Physiol Scand. 1997 Nov;161(3):345-53
pubmed: 9401587
Biochim Biophys Acta. 2007 Jun;1773(6):1000-6
pubmed: 17509700
Cardiovasc Res. 2016 Sep;111(4):338-47
pubmed: 27450980
Cardiovasc Res. 2012 Jun 1;94(3):460-8
pubmed: 22411972
BMJ. 2013 Feb 04;346:e8707
pubmed: 23386268
Am J Physiol Endocrinol Metab. 2014 Sep 15;307(6):E503-14
pubmed: 25074986
J Am Heart Assoc. 2018 Jan 6;7(1):
pubmed: 29306896
J Mol Cell Cardiol. 2016 Nov;100:43-53
pubmed: 27677939